Find clinical trials for Acute Myeloid Leukemia (AML) in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Warszawa, Mazowieckie, POL:
dose-escalation study that will determine the MTD and RP2D of L-Annamycin in combination with cytarabine for the treatment of subjects with AML...
Phase 1, Phase 2
Warsaw, Poland and 8 other locations
to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...
Phase 2
Warszawa, Mazowieckie, Poland and 56 other locations
This is a clinical study for adult patients who have recently been diagnosed with acute myeloid leukemia or AML. ...
Phase 3
Warszawa, Mazowieckie, Poland and 110 other locations
when administered to adult patients with relapsed or refractory acute myeloid leukemia (AML) or relapsed or progr...
Phase 2
Warszawa, Mazowieckie Województwo, Poland and 42 other locations
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefi...
Phase 3
Warszawa, Mazowieckie, Poland and 55 other locations
The purpose of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute ...
Phase 1
Warszawa, Poland and 22 other locations
This first-in-human study will evaluate RVU120 (SEL120), a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid L...
Phase 1
Warsaw, Poland and 9 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Warszawa, Poland and 251 other locations
administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed ...
Phase 2
Warszawa, Mazowieckie województwo, Poland and 33 other locations
available therapy (BAT) on overall survival (OS) in subjects with acute myeloid leukemia (AML) who are in second ...
Phase 3
Warsaw, Poland and 72 other locations
Clinical trials
Research sites
Resources
Legal